Intellectual Property India Publishes Patent Application for 'Gip/Glp1/Gcg Tri-Receptor Agonists And Uses Thereof' Filed by Eli Lilly And Company

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517074521 A) filed by Eli Lilly And Company, Indianapolis, on Aug. 5, for 'gip/glp1/gcg tri-receptor agonists and uses thereof.'

Inventor(s) include Abraham, Milata Mary; Brown, Robert Andrew; Coskun, Tamer; Flora, David Benjamin; Kleindl, Paul Joseph; Qu, Fucheng; Qu, Hongchang; and Wallis, James Lincoln.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "Polypeptides are provided that have activity at each of the GIP, GLP-1 and glucagon receptors. The polypeptides have structural features resulting in activity and extended duration of action...